Axoft

At a glance

Legal name

—unknownSource

1. v0 said 'Axoft, Inc.'; not pinned in primary Axoft sources

Updated: 2026-05-04

Aliases

—unknownUpdated: 2026-05-04

Type

university-spinoutverifiedSource

1. Harvard OTD — Axoft origin (Liu lab spinout)https://otd.harvard.edu/news/soft-safer-brain-implants/

Updated: 2026-05-04

Focus areas

medical-implant, research-gradeverifiedSources (2)

1. Axoft — official sitehttps://axoft.us
2. Axoft — $55M Series A press releasehttps://www.businesswire.com/news/home/20260429285106/en/Axoft-Secures-$55M-Series-A-to-Advance-Clinical-Trials-Globally-for-its-Bio-Inspired-Implantable-Brain-Computer-Interface2026-04-29

Updated: 2026-05-04

Founded

2021verifiedSource

1. Axoft — $55M Series A press releasehttps://www.businesswire.com/news/home/20260429285106/en/Axoft-Secures-$55M-Series-A-to-Advance-Clinical-Trials-Globally-for-its-Bio-Inspired-Implantable-Brain-Computer-Interface2026-04-29

Updated: 2026-05-04

Defunct

—unknownUpdated: 2026-05-04

Spinout of

Harvard University (Liu lab)verifiedSource

1. Harvard OTD — Axoft origin (Liu lab spinout)https://otd.harvard.edu/news/soft-safer-brain-implants/

Updated: 2026-05-04

HQ city

CambridgeverifiedSource

1. Axoft — $55M Series A press releasehttps://www.businesswire.com/news/home/20260429285106/en/Axoft-Secures-$55M-Series-A-to-Advance-Clinical-Trials-Globally-for-its-Bio-Inspired-Implantable-Brain-Computer-Interface2026-04-29

Updated: 2026-05-04

HQ country

USverifiedSource

1. Axoft — $55M Series A press releasehttps://www.businesswire.com/news/home/20260429285106/en/Axoft-Secures-$55M-Series-A-to-Advance-Clinical-Trials-Globally-for-its-Bio-Inspired-Implantable-Brain-Computer-Interface2026-04-29

Updated: 2026-05-04

Employees

—unknownUpdated: 2026-05-04

Flagship device

axoft-fleuronverifiedSource

1. Axoft — official sitehttps://axoft.us

Updated: 2026-05-04

Product lines

1verifiedSource

1. Axoft — official sitehttps://axoft.us

Updated: 2026-05-04

In-house manufacturing

—unknownUpdated: 2026-05-04

Open source

NoverifiedSource

1. Axoft — official sitehttps://axoft.us

Updated: 2026-05-04

GitHub org

—unknownUpdated: 2026-05-04

Website

axoft.usverifiedSource

1. Axoft — official sitehttps://axoft.us

Updated: 2026-05-04

Blog

—unknownUpdated: 2026-05-04

Support

—unknownUpdated: 2026-05-04

Devices

• invasivesingle-unit

  Fleuron

  axoft

  —USD 0

MilestonesverifiedSources (3)

1. Harvard OTD — Axoft origin (Liu lab spinout)https://otd.harvard.edu/news/soft-safer-brain-implants/
2. MassDevice — Axoft first human caseshttps://www.massdevice.com/axoft-completes-first-human-cases-with-ultrasoft-bci/
3. Axoft — $55M Series A press releasehttps://www.businesswire.com/news/home/20260429285106/en/Axoft-Secures-$55M-Series-A-to-Advance-Clinical-Trials-Globally-for-its-Bio-Inspired-Implantable-Brain-Computer-Interface2026-04-29

Updated: 2026-05-04

1. 2021

   Axoft launched out of Harvard's Liu lab

2. 2025

   First-in-human cases of the Fleuron iBCI

   Implanted in 4 patients undergoing brain tumor resection at The Panama Clinic (acute intraoperative recordings).

3. 2026-04-29

   $55M Series A

   Oversubscribed Series A to advance clinical trials globally; FDA-managed trial in TBI patients targeted for 2027.

Reputation

Distinguished by the Fleuron polymer's tissue-mimetic compliance. Markets explicitly against rigid Utah-array / silicon-shank approaches, betting on chronic biocompatibility as the durable competitive moat.